Amoxicillin/Vonoprazan Shortage Update: What Patients Need to Know in 2026

If your doctor prescribed Amoxicillin/Vonoprazan (Voquezna Dual Pak) for H. pylori and you're having trouble filling it, you might be wondering: is this a shortage? Here's everything patients need to know about Amoxicillin/Vonoprazan availability in 2026.

Is There an Official Shortage of Amoxicillin/Vonoprazan in 2026?

No. As of 2026, Amoxicillin/Vonoprazan (Voquezna Dual Pak) is not listed on the FDA Drug Shortage Database. This means there is no official, manufacturer-level supply disruption. Phathom Pharmaceuticals, the maker of Voquezna Dual Pak, has not reported any production problems or supply chain interruptions.

However, many patients across the U.S. still struggle to find it at their local pharmacy. This is a stocking and distribution issue — not a national shortage — and it's important to understand the difference.

Why Was Voquezna Dual Pak Delayed in the First Place?

Voquezna Dual Pak was FDA-approved in May 2022, but it didn't actually reach pharmacy shelves until December 2023 — a 19-month gap. The delay was caused by a regulatory hold related to the detection of trace levels of nitrosamine impurities in the formulation, a problem that affected multiple drugs in the early 2020s.

Once the impurity concern was resolved, the drug entered the market in late 2023. Because it launched relatively recently, pharmacies are still building their routine stocking patterns. This means there is a meaningful lag between when doctors started prescribing it and when all pharmacies began carrying it.

What Is the Current Availability Like in 2026?

Voquezna Dual Pak is:

• Available at most large chain pharmacies — CVS, Walgreens, and Walmart Pharmacy are your best bets.
• Inconsistently stocked at smaller pharmacies — Many independent pharmacies don't carry it routinely and may need 1–3 business days to order it.
• Available via mail-order — Insurance mail-order and Amazon Pharmacy can supply it with a prescription.
• Not under any manufacturer-level supply constraint — Supply at the wholesale level is intact.

How Does This Compare to the Amoxicillin Shortage?

It's important to distinguish Amoxicillin/Vonoprazan from plain amoxicillin. Amoxicillin oral suspension experienced a true FDA-listed shortage from 2022–2025, driven by pandemic-era demand surges and supply chain fragility. The FDA officially resolved that shortage on May 2, 2025.

Amoxicillin/Vonoprazan has never been in a formal FDA shortage. Its availability challenges are structural (new drug, brand-only, patchy pharmacy adoption) rather than supply-chain-driven.

Will Availability Improve?

Yes, most likely. As prescribers gain more experience with vonoprazan-based regimens — which recent ACG 2024 guidelines explicitly recommend as a first-line empiric alternative for H. pylori — more patients will be prescribed Voquezna Dual Pak. Increased prescription volume naturally encourages pharmacies to stock it more consistently.

The eventual availability of a generic vonoprazan would further improve accessibility, though no generic is currently approved in the U.S. Patent protections and exclusivities will determine when generic competition can enter the market.

What Should Patients Do Right Now?

If you're having trouble filling your Amoxicillin/Vonoprazan prescription in 2026:

1. Use medfinder.com to find pharmacies near you with Voquezna Dual Pak in stock.
2. Call multiple chain pharmacies — don't stop after one "no."
3. Ask your pharmacy to place a special order if they don't carry it routinely.
4. Contact your doctor if you cannot fill it within a few days — H. pylori shouldn't go untreated.
5. Ask your doctor about alternatives such as bismuth quadruple therapy (generic, ~$30–$80) if you can't find or afford Voquezna Dual Pak.

The Bottom Line

Amoxicillin/Vonoprazan is not in an FDA shortage in 2026, but it's not universally available either. The barriers are structural — newness, brand-only status, and pharmacy stocking patterns — and are expected to improve over time. In the meantime, proactive searching and a willingness to try alternatives will ensure your H. pylori gets treated. See: How to Find Amoxicillin/Vonoprazan In Stock Near You.